February 26, 2020 / 1:13 PM / a month ago

BRIEF-Alnylam Announces Approval In Brazil Of Onpattro

Feb 26 (Reuters) - Alnylam Pharmaceuticals Inc:

* ALNYLAM ANNOUNCES APPROVAL IN BRAZIL OF ONPATTRO® FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY

* ALNYLAM PHARMACEUTICALS - ONPATTRO IS FIRST-EVER RNAI THERAPEUTIC APPROVED IN LATIN AMERICA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below